Subclinical atherosclerosis measures for cardiovascular prediction in CKD
about
Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic ReviewUtility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKDThe Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney DiseaseMineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes.Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease.Pathophysiology of the chronic kidney disease-mineral bone disorder.Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKDChronic kidney disease in children.Baseline Cardiovascular Characteristics of Adult Patients with Chronic Kidney Disease from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate binders.The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.Zooming in on the genesis of atherosclerotic plaque microcalcifications.Cardiovascular risk prediction in people with chronic kidney disease.Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.Imaging Subclinical Atherosclerosis: Where Do We Stand?Mendelian Randomisation study of the influence of eGFR on coronary heart disease.Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease.Pro: cardiovascular calcifications are clinically relevant.Aspects of carotid structure and function in health and different stages of chronic kidney disease.A methodology review on the incremental prognostic value of computed tomography biomarkers in addition to Framingham risk score in predicting cardiovascular disease: the use of association, discrimination and reclassification.Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease.
P2860
Q26752715-98C43CB6-DB2A-46A8-A9B6-917D288D7B8BQ27027063-1251B4EF-33BA-4554-838F-3582D61F5F96Q35693460-9B88375A-B6EA-4447-B9C0-2E673B8CD1E2Q36114992-159B9E73-1C4C-4012-9228-A585979CC783Q36141979-28518F2D-D488-4787-BFD2-D6FD8CD3F171Q36143198-6B6FF2DB-599B-45B8-B5DB-CC2B9A0E3BD0Q36425115-9A388B08-FC8D-4FC2-9D67-BDED09ED404EQ36905955-FE3CEBB0-0966-44DD-A14F-01A7E663AF54Q37069998-7FA1505B-E1EF-4759-B96D-2E69AEBFE5AFQ37119068-9C34B2E2-11F6-409B-A02A-D4D4028F3968Q37570158-46B1C930-B2FA-4967-80E9-16E95E4361D9Q37673143-F2A77002-0100-4A53-867B-45E9FBA2EFEAQ38389206-36BF0F3A-0436-4A3A-B309-FC8945777C2EQ38711321-33EA4418-1267-428D-9349-97E4F4031E97Q38796978-9C883F1B-B5D9-4B69-8CBA-EA8DDF4EE570Q38811233-5D342484-463F-4A27-8802-FBF224AE7176Q38886579-E783CC33-F006-4F80-9E78-D09E582443F0Q38918899-9DEE8B4C-2587-46C6-9EAD-FCC5EF61CF79Q38939614-0A25BA07-CE4C-49A8-BF4D-5A53CC41F167Q38977586-BC22798C-D8DA-436F-B343-41A5D04BC18EQ39101623-8B408BE8-17C6-4E10-88FF-DD72223EBD2FQ39757983-59694132-28E9-4169-B425-2538BF3F563EQ40471430-DAFF9200-386A-40FC-8BF0-26C8E39F6790Q41354300-1A77BDF4-71E4-44E6-BFEE-E2FF716372C7Q48262897-3EFEE79E-1F81-4D9D-BF48-290471480599Q50318034-6CE7407F-B64C-48C0-A2C7-7DF9C66B82D1Q55476169-1AB2E85C-E276-400D-A96E-B77E83DE81A2
P2860
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@ast
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@en
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@nl
type
label
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@ast
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@en
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@nl
prefLabel
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@ast
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@en
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@nl
P2093
P2860
P50
P3181
P356
P1476
Subclinical atherosclerosis measures for cardiovascular prediction in CKD
@en
P2093
Carmen A Peralta
David R Jacobs
Holly J Kramer
Kunihiro Matsushita
Mark J Sarnak
Mark Woodward
Shoshana H Ballew
Sylvia E Rosas
Yingying Sang
P2860
P304
P3181
P356
10.1681/ASN.2014020173
P407
P577
2015-02-01T00:00:00Z